跳至主要内容
临床试验/CTRI/2023/04/051702
CTRI/2023/04/051702招募中Unknown

A Prospective Real-world Cohort Study to Validate Effectiveness of an Artificial Intelligence defined Lung Nodule Malignancy Score in Patients With Pulmonary Nodule - CREATE

AstraZenca0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients diagnosed with incidental pulmonary nodules on CXR by qXR and confirmed by the radiologist at the site with nodule size =8 and =30 mm.

排除标准

  • 1. Any medical or other contraindications for a CT scan
  • 2. Nondigital CXR
  • 3. CT scan is done more than 6 months after CXR
  • 4. Patients with already diagnosed LC
  • 5. The patients referred for an X-Ray for a suspicious LC
  • 6. A patient who already participated in the study.

研究者

发起方
AstraZenca

相似试验